The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

Global Plasma Protein Therapeutics Market Research Report 2024

Global Plasma Protein Therapeutics Market Research Report 2024

Publishing Date : Jan, 2024

License Type :
 

Report Code : 1419223

No of Pages : 93

Ask Your Query

Synopsis

Plasma Protein Therapeutics is use blood products to treat disease.Human blood plasma is nature's raw material for dozens of life-saving treatments and medications. By extracting the active ingredients and disinfection, people get related preparations from blood plasma, which is called blood product.

The global Plasma Protein Therapeutics market was valued at US$ 28070 million in 2023 and is anticipated to reach US$ 44730 million by 2030, witnessing a CAGR of 6.8% during the forecast period 2024-2030.

Shire (Baxalta), CSL and Grifolsare the leaders of the Plasma Protein Therapeutics industry, which take about 55% market share. China is the major region of the global market, which takes about 45% market share.

This report aims to provide a comprehensive presentation of the global market for Plasma Protein Therapeutics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Plasma Protein Therapeutics.

Report Scope

The Plasma Protein Therapeutics market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Plasma Protein Therapeutics market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Plasma Protein Therapeutics manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

By Company

  • Shire (Baxalta)
  • CSL
  • Grifols
  • Octapharma
  • Kedrion
  • LFB Group
  • Biotest
  • BPL
  • RAAS
  • CBPO
  • Hualan Bio
  • Kamada

Segment by Type

  • Coagulation Factor
  • Immune Globulin
  • Albumin
  • Others

Segment by Application

  • Hemophilia
  • PID
  • Others

Consumption by Region

  • North America (United States, Canada)
  • Europe (Germany, France, U.K., Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, India, Australia, China Taiwan, Indonesia, Thailand, Malaysia)
  • Latin America (Mexico, Brazil, Argentina)
  • Middle East & Africa (Turkey, Saudi Arabia, UAE)

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Plasma Protein Therapeutics manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Plasma Protein Therapeutics in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.

Index

1 Plasma Protein Therapeutics Market Overview
1.1 Product Overview and Scope of Plasma Protein Therapeutics
1.2 Plasma Protein Therapeutics Segment by Type
1.2.1 Global Plasma Protein Therapeutics Market Value Comparison by Type (2024-2030)
1.2.2 Coagulation Factor
1.2.3 Immune Globulin
1.2.4 Albumin
1.2.5 Others
1.3 Plasma Protein Therapeutics Segment by Application
1.3.1 Global Plasma Protein Therapeutics Market Value by Application: (2024-2030)
1.3.2 Hemophilia
1.3.3 PID
1.3.4 Others
1.4 Global Plasma Protein Therapeutics Market Size Estimates and Forecasts
1.4.1 Global Plasma Protein Therapeutics Revenue 2019-2030
1.4.2 Global Plasma Protein Therapeutics Sales 2019-2030
1.4.3 Global Plasma Protein Therapeutics Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Plasma Protein Therapeutics Market Competition by Manufacturers
2.1 Global Plasma Protein Therapeutics Sales Market Share by Manufacturers (2019-2024)
2.2 Global Plasma Protein Therapeutics Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Plasma Protein Therapeutics Average Price by Manufacturers (2019-2024)
2.4 Global Plasma Protein Therapeutics Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Plasma Protein Therapeutics, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Plasma Protein Therapeutics, Product Type & Application
2.7 Plasma Protein Therapeutics Market Competitive Situation and Trends
2.7.1 Plasma Protein Therapeutics Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Plasma Protein Therapeutics Players Market Share by Revenue
2.7.3 Global Plasma Protein Therapeutics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Plasma Protein Therapeutics Retrospective Market Scenario by Region
3.1 Global Plasma Protein Therapeutics Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Plasma Protein Therapeutics Global Plasma Protein Therapeutics Sales by Region: 2019-2030
3.2.1 Global Plasma Protein Therapeutics Sales by Region: 2019-2024
3.2.2 Global Plasma Protein Therapeutics Sales by Region: 2025-2030
3.3 Global Plasma Protein Therapeutics Global Plasma Protein Therapeutics Revenue by Region: 2019-2030
3.3.1 Global Plasma Protein Therapeutics Revenue by Region: 2019-2024
3.3.2 Global Plasma Protein Therapeutics Revenue by Region: 2025-2030
3.4 North America Plasma Protein Therapeutics Market Facts & Figures by Country
3.4.1 North America Plasma Protein Therapeutics Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Plasma Protein Therapeutics Sales by Country (2019-2030)
3.4.3 North America Plasma Protein Therapeutics Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Plasma Protein Therapeutics Market Facts & Figures by Country
3.5.1 Europe Plasma Protein Therapeutics Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Plasma Protein Therapeutics Sales by Country (2019-2030)
3.5.3 Europe Plasma Protein Therapeutics Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Plasma Protein Therapeutics Market Facts & Figures by Country
3.6.1 Asia Pacific Plasma Protein Therapeutics Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Plasma Protein Therapeutics Sales by Country (2019-2030)
3.6.3 Asia Pacific Plasma Protein Therapeutics Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Plasma Protein Therapeutics Market Facts & Figures by Country
3.7.1 Latin America Plasma Protein Therapeutics Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Plasma Protein Therapeutics Sales by Country (2019-2030)
3.7.3 Latin America Plasma Protein Therapeutics Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Plasma Protein Therapeutics Market Facts & Figures by Country
3.8.1 Middle East and Africa Plasma Protein Therapeutics Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Plasma Protein Therapeutics Sales by Country (2019-2030)
3.8.3 Middle East and Africa Plasma Protein Therapeutics Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Plasma Protein Therapeutics Sales by Type (2019-2030)
4.1.1 Global Plasma Protein Therapeutics Sales by Type (2019-2024)
4.1.2 Global Plasma Protein Therapeutics Sales by Type (2025-2030)
4.1.3 Global Plasma Protein Therapeutics Sales Market Share by Type (2019-2030)
4.2 Global Plasma Protein Therapeutics Revenue by Type (2019-2030)
4.2.1 Global Plasma Protein Therapeutics Revenue by Type (2019-2024)
4.2.2 Global Plasma Protein Therapeutics Revenue by Type (2025-2030)
4.2.3 Global Plasma Protein Therapeutics Revenue Market Share by Type (2019-2030)
4.3 Global Plasma Protein Therapeutics Price by Type (2019-2030)
5 Segment by Application
5.1 Global Plasma Protein Therapeutics Sales by Application (2019-2030)
5.1.1 Global Plasma Protein Therapeutics Sales by Application (2019-2024)
5.1.2 Global Plasma Protein Therapeutics Sales by Application (2025-2030)
5.1.3 Global Plasma Protein Therapeutics Sales Market Share by Application (2019-2030)
5.2 Global Plasma Protein Therapeutics Revenue by Application (2019-2030)
5.2.1 Global Plasma Protein Therapeutics Revenue by Application (2019-2024)
5.2.2 Global Plasma Protein Therapeutics Revenue by Application (2025-2030)
5.2.3 Global Plasma Protein Therapeutics Revenue Market Share by Application (2019-2030)
5.3 Global Plasma Protein Therapeutics Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Shire (Baxalta)
6.1.1 Shire (Baxalta) Corporation Information
6.1.2 Shire (Baxalta) Description and Business Overview
6.1.3 Shire (Baxalta) Plasma Protein Therapeutics Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Shire (Baxalta) Plasma Protein Therapeutics Product Portfolio
6.1.5 Shire (Baxalta) Recent Developments/Updates
6.2 CSL
6.2.1 CSL Corporation Information
6.2.2 CSL Description and Business Overview
6.2.3 CSL Plasma Protein Therapeutics Sales, Revenue and Gross Margin (2019-2024)
6.2.4 CSL Plasma Protein Therapeutics Product Portfolio
6.2.5 CSL Recent Developments/Updates
6.3 Grifols
6.3.1 Grifols Corporation Information
6.3.2 Grifols Description and Business Overview
6.3.3 Grifols Plasma Protein Therapeutics Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Grifols Plasma Protein Therapeutics Product Portfolio
6.3.5 Grifols Recent Developments/Updates
6.4 Octapharma
6.4.1 Octapharma Corporation Information
6.4.2 Octapharma Description and Business Overview
6.4.3 Octapharma Plasma Protein Therapeutics Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Octapharma Plasma Protein Therapeutics Product Portfolio
6.4.5 Octapharma Recent Developments/Updates
6.5 Kedrion
6.5.1 Kedrion Corporation Information
6.5.2 Kedrion Description and Business Overview
6.5.3 Kedrion Plasma Protein Therapeutics Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Kedrion Plasma Protein Therapeutics Product Portfolio
6.5.5 Kedrion Recent Developments/Updates
6.6 LFB Group
6.6.1 LFB Group Corporation Information
6.6.2 LFB Group Description and Business Overview
6.6.3 LFB Group Plasma Protein Therapeutics Sales, Revenue and Gross Margin (2019-2024)
6.6.4 LFB Group Plasma Protein Therapeutics Product Portfolio
6.6.5 LFB Group Recent Developments/Updates
6.7 Biotest
6.6.1 Biotest Corporation Information
6.6.2 Biotest Description and Business Overview
6.6.3 Biotest Plasma Protein Therapeutics Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Biotest Plasma Protein Therapeutics Product Portfolio
6.7.5 Biotest Recent Developments/Updates
6.8 BPL
6.8.1 BPL Corporation Information
6.8.2 BPL Description and Business Overview
6.8.3 BPL Plasma Protein Therapeutics Sales, Revenue and Gross Margin (2019-2024)
6.8.4 BPL Plasma Protein Therapeutics Product Portfolio
6.8.5 BPL Recent Developments/Updates
6.9 RAAS
6.9.1 RAAS Corporation Information
6.9.2 RAAS Description and Business Overview
6.9.3 RAAS Plasma Protein Therapeutics Sales, Revenue and Gross Margin (2019-2024)
6.9.4 RAAS Plasma Protein Therapeutics Product Portfolio
6.9.5 RAAS Recent Developments/Updates
6.10 CBPO
6.10.1 CBPO Corporation Information
6.10.2 CBPO Description and Business Overview
6.10.3 CBPO Plasma Protein Therapeutics Sales, Revenue and Gross Margin (2019-2024)
6.10.4 CBPO Plasma Protein Therapeutics Product Portfolio
6.10.5 CBPO Recent Developments/Updates
6.11 Hualan Bio
6.11.1 Hualan Bio Corporation Information
6.11.2 Hualan Bio Plasma Protein Therapeutics Description and Business Overview
6.11.3 Hualan Bio Plasma Protein Therapeutics Sales, Revenue and Gross Margin (2019-2024)
6.11.4 Hualan Bio Plasma Protein Therapeutics Product Portfolio
6.11.5 Hualan Bio Recent Developments/Updates
6.12 Kamada
6.12.1 Kamada Corporation Information
6.12.2 Kamada Plasma Protein Therapeutics Description and Business Overview
6.12.3 Kamada Plasma Protein Therapeutics Sales, Revenue and Gross Margin (2019-2024)
6.12.4 Kamada Plasma Protein Therapeutics Product Portfolio
6.12.5 Kamada Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Plasma Protein Therapeutics Industry Chain Analysis
7.2 Plasma Protein Therapeutics Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Plasma Protein Therapeutics Production Mode & Process
7.4 Plasma Protein Therapeutics Sales and Marketing
7.4.1 Plasma Protein Therapeutics Sales Channels
7.4.2 Plasma Protein Therapeutics Distributors
7.5 Plasma Protein Therapeutics Customers
8 Plasma Protein Therapeutics Market Dynamics
8.1 Plasma Protein Therapeutics Industry Trends
8.2 Plasma Protein Therapeutics Market Drivers
8.3 Plasma Protein Therapeutics Market Challenges
8.4 Plasma Protein Therapeutics Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer

Published By : QY Research

Why ‘The Market Reports’

In Business: Pre Sales Support: Post Sales Support: Turn Around Time: Clients Served: Clients Assisted: Client Types: Payment: Partners with: Number of reports: Custom Research: Report Availability: Report Delivery Format: Security:

Payments Accepted From

Connect with us at

Complete Secure Website

SiteLock